Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth G Saag

Showing results (21-30 of 374) with videos related to

Pageof 38
Sort By:
Arthritis Research & Therapy|October 24, 2009
Progress in osteoporosis and fracture prevention: focus on postmenopausal womenKenneth G Saag, Piet Geusens
Rheumatic Diseases Clinics of North America|November 28, 2015
Glucocorticoid-induced OsteoporosisXena Whittier, Kenneth G Saag
Nature Clinical Practice. Rheumatology|September 5, 2007
Treatment of acute gout-like arthritis in an emergency setting: prednisolone versus indomethacinAngelo Gaffo, Kenneth G Saag
Arthritis Research & Therapy|July 6, 2006
Epidemiology, risk factors, and lifestyle modifications for goutKenneth G Saag, Hyon Choi
Best Practice & Research. Clinical Rheumatology|November 8, 2022
Risk for osteoporosis and fracture with glucocorticoidsMariana Urquiaga, Kenneth G Saag
Pharmacoepidemiology and Drug Safety|June 2, 2006
Unbalanced regulation of over-the-counter analgesics: the lesser of two evils?Jeroan J Allison, Kenneth G Saag
Nature Clinical Practice. Rheumatology|December 3, 2008
Are glucocorticoids equivalent to NSAIDs for the treatment of gout flares?Angelo L Gaffo, Kenneth G Saag
Annals of Internal Medicine|June 7, 2017
Management of GoutJasvinder A Singh, Kenneth G Saag
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|December 30, 2011
Drug treatment of hyperuricemia to prevent cardiovascular outcomes: are we there yet?Angelo L Gaffo, Kenneth G Saag
Arthritis Care & Research|February 27, 2020
Imminent Fracture Risk: A Call to Action for RheumatologistsMaria I Danila, Kenneth G Saag
Pageof 38

Showing results (21-30 of 374) with videos related to

Sort By:
Pageof 38
Arthritis Research & Therapy|October 24, 2009
Progress in osteoporosis and fracture prevention: focus on postmenopausal womenKenneth G Saag, Piet Geusens
Rheumatic Diseases Clinics of North America|November 28, 2015
Glucocorticoid-induced OsteoporosisXena Whittier, Kenneth G Saag
Nature Clinical Practice. Rheumatology|September 5, 2007
Treatment of acute gout-like arthritis in an emergency setting: prednisolone versus indomethacinAngelo Gaffo, Kenneth G Saag
Arthritis Research & Therapy|July 6, 2006
Epidemiology, risk factors, and lifestyle modifications for goutKenneth G Saag, Hyon Choi
Best Practice & Research. Clinical Rheumatology|November 8, 2022
Risk for osteoporosis and fracture with glucocorticoidsMariana Urquiaga, Kenneth G Saag
Pharmacoepidemiology and Drug Safety|June 2, 2006
Unbalanced regulation of over-the-counter analgesics: the lesser of two evils?Jeroan J Allison, Kenneth G Saag
Nature Clinical Practice. Rheumatology|December 3, 2008
Are glucocorticoids equivalent to NSAIDs for the treatment of gout flares?Angelo L Gaffo, Kenneth G Saag
Annals of Internal Medicine|June 7, 2017
Management of GoutJasvinder A Singh, Kenneth G Saag
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|December 30, 2011
Drug treatment of hyperuricemia to prevent cardiovascular outcomes: are we there yet?Angelo L Gaffo, Kenneth G Saag
Arthritis Care & Research|February 27, 2020
Imminent Fracture Risk: A Call to Action for RheumatologistsMaria I Danila, Kenneth G Saag
Pageof 38